Skip to main content

Table 5 OS, 30-day, 3-month and 6-month mortality of discussed risk scoring

From: Prognostic assessment for patients with cancer and incidental pulmonary embolism

Score categories

OS months (95%CI)

Mortality %(n)

30-d (n = 7)

3-m (n = 33)

6-m (n = 68)

Hull5 Risk Score (n = 227)

Low (n = 45)

32(8.1,5 5.9)

0(0)

2.2(1)

4.4(2)

Intermediate (n = 115)

12.6(8.3, 16.9)

0.9(1)

11.3(13)

25.2(29)

High (n = 67)

5.5 (3.9, 7.2)

9.0(6)

28.4(19)

55.2(37)

 

p < .001*

p = .004**

p < .001**

p < .001**

RIETE Risk Score (n = 205)

Very low (n = 27)

not reached

0(0)

3.7(1)

7.4(2)

Low (n = 123)

15.9 (11.2, 20.6)

2.4(3)

9.8(12)

22.8(28)

Intermediate (n = 53)

5.4 (4.3, 6.5)

5.7(3)

32.1(17)

56.6(30)

High (n = 2)

2.7 (not calc.)

0%(0)

50(1)

50(1)

 

p < .001*

p = .185**

p < .001**

p < .001**

RIETE Risk Score (n = 205)

Low(n = 27)

not reached

0(0)

3.7(1)

7.4(2)

High (n = 178)

11.2 (7.7, 14.7)

3.4(6)

16.9(30)

33.1(59)

 

p < .001*

p = .603**

p = .087**

p = .006**

  1. *log rank (pooled)
  2. **Kendall’s tau-b exact test